Alexander Akhiezer

Alexander “Alex” Akhiezer is a partner in Foley Hoag's Intellectual Property Department, where his primary focus is on emergent technologies that operate at the intersection of chemistry, biology, and physics.

Alex’s practice emphasizes patent life cycle management and venture capital IP due diligence. He has participated in corporate acquisitions, drafted and negotiated portfolio license agreements, and prepared opinions of counsel on matters of infringement and validity.

In the field of chemistry, Alex's practice encompasses medicinal chemistry (including small molecules and formulations), physical chemistry (including organic light-emitting diodes), and computational methods (including molecular modeling, crystallography, and structural biology). He also advises clients in the areas of polymer chemistry (biodegradeable polymers, photopolymers, conducting organic polymers) and composite materials.

Good to know

Job Types Attorney
Areas of Practice 1) Patent Prosecution, 2) PTAB Proceedings and 3) Licensing & Strategic Alliances
Law School Suffolk University Law School (J.D.,2007)
Education Massachusetts Institute of Technology(Ph.D.,2002);New York University (B.A.,1996)
Bar Member / Association Massachusetts State Bar Association
Most recent firm Foley Hoag LLP
LinkedIn Profile https://www.linkedin.com/in/alexander-akhiezer-8056a82
Barbara A. Fitzgerald
Barbara A. Fitzgerald

Ms. Fitzgerald represents employers in a wide range of industries, including the entertainment, financial services, hospitality, manufacturing, retail, and transportation industries.

Barton W S Bassett
Barton W S Bassett

Barton W.S. Bassett is the leader of Morgan Lewis's Tax Practice. Mr. Bassett's practice focuses on international tax planning for both the outbound operations of U.S. multinationals and the inbound operations of foreign multinationals.

Benjamin P. Smith
Benjamin P. Smith

Benjamin P. Smith is a partner in Morgan Lewis's Litigation Practice. He is a trial lawyer with a particular focus on high-stakes disputes in the biotechnology, medical device, and internet industries.